The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Cell & Gene
    • Bioprocessing
    • Drug Delivery
    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Regulation & Standards
    • Small Molecules
    • Supply Chain
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Webinars / 2021 / Critical Quality Attributes for supply of clinical plasmids for cell and gene therapy development
Manufacture Bioprocessing

Critical Quality Attributes for supply of clinical plasmids for cell and gene therapy development

Join this webinar to learn what attributes across the manufacturing process impact quality.

07/01/2021

Sponsored By

Share


Available On-demand

Overview:

Plasmid DNA is a critical raw material for establishing the genetic basis for cell & gene therapy medicines and a sourcing challenge for many innovators. From long-lead times for plasmid manufacturing slots to an evolving regulatory environment, innovators are seeking the highest quality materials to meet aggressive timelines and continue to the next phase of development. As quality can be a nebulous term, join this webinar to learn what attributes across the manufacturing process impact quality and how GMP-quality plasmids can enable your cell and gene therapy manufacturing.

Learning objectives:

  • Why plasmid quality is critical to patient safety

  • Value of quality and what quality looks like

  • Avoidance of delays by using gmp-grade material from the onset of project

Visit Our Webinar Hub

Newsletters

Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

November 29, 2021

Umicore roundtable on cross-coupling catalysis

Drug Discovery

September 28, 2021

How analytical techniques evolve and support biopharmaceutical drug development?

Drug Discovery

July 27, 2021

Tired of Manual Staining? Meet the LabSat® Research Platform

Recommended

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions: